Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3644006
Max Phase: Preclinical
Molecular Formula: C20H27N5O2
Molecular Weight: 369.47
Molecule Type: Small molecule
Associated Items:
ID: ALA3644006
Max Phase: Preclinical
Molecular Formula: C20H27N5O2
Molecular Weight: 369.47
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H]1CN(c2ncc(-c3cccc(CN(C)C(=O)CN)c3)cn2)C[C@H](C)O1
Standard InChI: InChI=1S/C20H27N5O2/c1-14-11-25(12-15(2)27-14)20-22-9-18(10-23-20)17-6-4-5-16(7-17)13-24(3)19(26)8-21/h4-7,9-10,14-15H,8,11-13,21H2,1-3H3/t14-,15+
Standard InChI Key: DXHATKDTFCBJTO-GASCZTMLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 369.47 | Molecular Weight (Monoisotopic): 369.2165 | AlogP: 1.67 | #Rotatable Bonds: 5 |
Polar Surface Area: 84.58 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.13 | CX LogP: 1.34 | CX LogD: 0.54 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.86 | Np Likeness Score: -1.37 |
1. (2014) Glycine compound, |
Source(1):